약국 급여 관리자(PBM) 시장 : 제품 유형별, 최종 사용자별, 지역별 - 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

Persistence Market Research provides an in-depth analysis of the Pharmacy Benefit Manager (PBM) Market, highlighting key aspects of its development and expected growth from 2024 to 2032. This report delves into market trends, drivers, challenges, and the emerging landscape, offering vital statistics and projections.

Key Insights:

• Pharmacy Benefit Manager Market Size (2024): USD 632.9 Billion
• Projected Market Value (2032): USD 1,050 Billion
• Global Market Growth Rate (CAGR 2024 to 2032): 7.5%

Pharmacy Benefit Manager Market - Report Scope:

The PBM market is integral to the healthcare sector, streamlining prescription drug processes and improving cost efficiency for insurers and consumers. PBMs play a crucial role in negotiating with drug manufacturers and pharmacies to manage drug formularies, ensuring competitive pricing and facilitating medication adherence programs. The market's expansion is propelled by the growing demand for cost-effective healthcare solutions and the increasing burden of chronic diseases globally.

Market Growth Drivers:

Several factors drive the growth of the PBM market. The rising cost of healthcare and prescription drugs compels insurers and employers to seek efficient ways to manage drug spending. Additionally, the increasing prevalence of chronic diseases necessitates effective medication management programs, which PBMs facilitate. Technological advancements in data analytics and health IT systems further enhance PBMs' ability to manage healthcare costs effectively and improve patient outcomes.

Market Restraints:

However, the PBM market faces challenges such as regulatory scrutiny over reimbursement policies and potential conflicts of interest. Concerns about transparency and the true benefit of cost savings to consumers also pose significant hurdles. Additionally, the consolidation of the market may limit competition and innovation within the industry.

Market Opportunities:

The evolving healthcare landscape offers numerous opportunities for PBMs. There is a growing emphasis on personalized medicine and value-based care models, which can integrate seamlessly with PBM services to optimize therapy outcomes and control costs. Expansion into global markets and diversification into other healthcare services can also provide growth avenues for PBMs.

Key Questions Answered in the Report:

• What are the primary factors driving the global growth of the Pharmacy Benefit Manager market?
• How are advancements in technology and shifts in healthcare policies affecting PBMs?
• What challenges do PBMs face in the current healthcare environment, and how can these be mitigated?
• Which strategies are leading PBMs adopting to sustain competitiveness and address market demands?
• How is the role of PBMs evolving in the face of healthcare reforms and changes in drug pricing policies?

Competitive Intelligence and Business Strategy:

Leading players in the PBM market focus on leveraging technology to enhance service offerings, improve patient engagement, and ensure compliance with changing healthcare regulations. Companies invest in advanced health IT solutions to streamline operations and offer tailored programs that promote medication adherence and patient education. Strategic partnerships with healthcare providers, insurers, and technology firms also help PBMs expand their capabilities and reach in the competitive market.

Key Companies Profiled:

• Express Scripts Holding Company
• CVS Health Corporation
• DST Systems, Inc.
• Rite Aid Corp.
• ProCare Rx.
• UnitedHealth Group
• Benecard Services, LLC
• BioScrip, Inc.
• CaptureRx
• Change Healthcare

Pharmacy Benefit Manager Market Research Segmentation:

By Service:

• Retail Pharmacy Services
• Specialty Pharmacy Services
• Benefit Plan Design and Consultation
• Drug Formulary Management
• Other Services

By Demand Determinant:

• Government Health Programs
• Employer-Sponsored Programs
• Health Insurance Companies
• Other Programs

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Market Overview
• 1.2. Market Analysis
• 1.3. Analysis and Recommendations
• 1.4. Wheel of Fortune

2. Market Introduction

• 2.1. Market Taxonomy
• 2.2. Market Definition

3. Market Background

• 3.1. Macroeconomic Factors
• 3.2. Forecast Factors: Relevance & Impact
• 3.3. Value Chain Analysis
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Challenge
  • 3.4.3. Opportunity Analysis

4. Market Forecast

• 4.1. Market Size Projections
  • 4.1.1. Y-o-Y Projections
  • 4.1.2. Absolute $ Opportunity Analysis

5. Global Pharmacy Benefit Manager Market Analysis by Service

• 5.1. Introduction
  • 5.1.1. Market Value Share Analysis by Service
  • 5.1.2. Y-o-Y Growth Analysis by Service
• 5.2. Historical Market Size Analysis by Service, 2019-2023
• 5.3. Market Size Forecast by Service, 2024-2032
  • 5.3.1. Retail Pharmacy Services
  • 5.3.2. Specialty Pharmacy Services
  • 5.3.3. Benefit Plan Design and Consultation
  • 5.3.4. Drug Formulary Management
  • 5.3.5. Other Services
• 5.4. Market Attractiveness Analysis by Service

6. Global Pharmacy Benefit Manager Market Analysis by Demand Determinant

• 6.1. Introduction
  • 6.1.1. Market Value Share Analysis by Demand Determinant
  • 6.1.2. Y-o-Y Growth Analysis by Demand Determinant
• 6.2. Historical Market Size Analysis by Demand Determinant, 2019-2023
• 6.3. Market Size Forecast by Demand Determinant, 2024-2032
  • 6.3.1. Government Heath Programs
  • 6.3.2. Employer-sponsored Programs
  • 6.3.3. Health Insurance Management
  • 6.3.4. Other Services
• 6.4. Market Attractiveness Analysis by Demand Determinant

7. Global Pharmacy Benefit Manager Market Analysis by Region

• 7.1. Introduction
  • 7.1.1. Market Value Share Analysis by Region
  • 7.1.2. Y-o-Y Growth Analysis by Region
• 7.2. Historical Market Size Analysis by Region, 2019-2023
• 7.3. Market Size Forecast by Region, 2024-2032
  • 7.3.1. North America
  • 7.3.2. Latin America
  • 7.3.3. Europe
  • 7.3.4. SEA and Others of APAC
  • 7.3.5. China
  • 7.3.6. Japan
  • 7.3.7. Middle East and Africa
• 7.4. Market Attractiveness Analysis by Region

8. North America Pharmacy Benefit Manager Market Analysis

• 8.1. Introduction
• 8.2. Historical Market Size Analysis by Market Segment, 2019-2023
• 8.3. Market Size Forecast by Market Segment, 2024-2032
  • 8.3.1. By Country
    • 8.3.1.1. U.S.
    • 8.3.1.2. Canada
  • 8.3.2. By Service
  • 8.3.3. By Demand Determinant
• 8.4. Market Attractiveness Analysis
  • 8.4.1. By Country
  • 8.4.2. By Service
  • 8.4.3. By Demand Determinant
• 8.5. Market Trend
• 8.6. Drivers and Restraints - Impact Analysis

9. Latin America Pharmacy Benefit Manager Market Analysis

• 9.1. Introduction
• 9.2. Historical Market Size Analysis by Market Segment, 2019-2023
• 9.3. Market Size Forecast by Market Segment, 2024-2032
  • 9.3.1. By Country
    • 9.3.1.1. Brazil
    • 9.3.1.2. Mexico
    • 9.3.1.3. Rest of Latin America
  • 9.3.2. By Service
  • 9.3.3. By Demand Determinant
• 9.4. Market Attractiveness Analysis
  • 9.4.1. By Country
  • 9.4.2. By Service
  • 9.4.3. By Demand Determinant
• 9.5. Market Trend
• 9.6. Drivers and Restraints - Impact Analysis

10. Europe Pharmacy Benefit Manager Market Analysis

• 10.1. Introduction
• 10.2. Historical Market Size Analysis by Market Segment, 2019-2023
• 10.3. Market Size Forecast by Market Segment, 2024-2032
  • 10.3.1. By Country
    • 10.3.1.1. Germany
    • 10.3.1.2. Italy
    • 10.3.1.3. France
    • 10.3.1.4. U.K.
    • 10.3.1.5. Spain
    • 10.3.1.6. Russia
    • 10.3.1.7. Rest of Europe
  • 10.3.2. By Service
  • 10.3.3. By Demand Determinant
• 10.4. Market Attractiveness Analysis
  • 10.4.1. By Country
  • 10.4.2. By Service
  • 10.4.3. By Demand Determinant
• 10.5. Market Trend
• 10.6. Drivers and Restraints - Impact Analysis

11. China Pharmacy Benefit Manager Market Analysis

• 11.1. Introduction
• 11.2. Historical Market Size Analysis by Market Segment, 2019-2023
• 11.3. Market Size Forecast by Market Segment, 2024-2032
  • 11.3.1. By Service
  • 11.3.2. By Demand Determinant
• 11.4. Market Attractiveness Analysis
  • 11.4.1. By Service
  • 11.4.2. By Demand Determinant
• 11.5. Market Trend
• 11.6. Drivers and Restraints - Impact Analysis

12. Japan Pharmacy Benefit Manager Market Analysis

• 12.1. Introduction
• 12.2. Historical Market Size Analysis by Market Segment, 2019-2023
• 12.3. Market Size Forecast by Market Segment, 2024-2032
  • 12.3.1. By Service
  • 12.3.2. By Demand Determinant
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Service
  • 12.4.2. By Demand Determinant
• 12.5. Market Trend
• 12.6. Drivers and Restraints - Impact Analysis

13. SEA and Others of APAC Pharmacy Benefit Manager Market Analysis

• 13.1. Introduction
• 13.2. Historical Market Size Analysis by Market Segment, 2019-2023
• 13.3. Market Size Forecast by Market Segment, 2024-2032
  • 13.3.1. By Country
    • 13.3.1.1. India
    • 13.3.1.2. ASEAN
    • 13.3.1.3. Australia and New Zealand
    • 13.3.1.4. Rest of SEA and Others of APAC
  • 13.3.2. By Service
  • 13.3.3. By Demand Determinant
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Service
  • 13.4.3. By Demand Determinant
• 13.5. Market Trend
• 13.6. Drivers and Restraints - Impact Analysis

14. Middle East & Africa Pharmacy Benefit Manager Market Analysis

• 14.1. Introduction
• 14.2. Historical Market Size Analysis by Market Segment, 2019-2023
• 14.3. Market Size Forecast by Market Segment, 2024-2032
  • 14.3.1. By Country
    • 14.3.1.1. Northern Africa
    • 14.3.1.2. GCC Countries
    • 14.3.1.3. South Africa
    • 14.3.1.4. Turkey
    • 14.3.1.5. Rest of Middle East and Africa
  • 14.3.2. By Service
  • 14.3.3. By Demand Determinant
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Service
  • 14.4.3. By Demand Determinant
• 14.5. Market Trend
• 14.6. Drivers and Restraints - Impact Analysis

15. Market Structure Analysis

• 15.1. Market Analysis by Tier of Companies
  • 15.1.1. By Large, Medium and Small
• 15.2. Market Concentration
  • 15.2.1. By Top 5 and by Top 10
• 15.3. Market Share Analysis of Top 10 Players

16. Competition Analysis

• 16.1. Competition Dashboard
• 16.2. Competition Deep Dive
  • 16.2.1. Express Scripts Holding Company
    • 16.2.1.1. Overview
    • 16.2.1.2. Product Portfolio
    • 16.2.1.3. Sales Footprint
    • 16.2.1.4. Channel Footprint
    • 16.2.1.6. Strategy
      • 16.2.1.6.1. Marketing Strategy
      • 16.2.1.6.2. Product Strategy
      • 16.2.1.6.3. Channel Strategy
  • 16.2.2. CVS Health Corporation
    • 16.2.2.1. Overview
    • 16.2.2.2. Product Portfolio
    • 16.2.2.3. Sales Footprint
    • 16.2.2.4. Channel Footprint
    • 16.2.2.6. Strategy
      • 16.2.2.6.1. Marketing Strategy
      • 16.2.2.6.2. Product Strategy
      • 16.2.2.6.3. Channel Strategy
  • 16.2.3. DST Systems, Inc.
    • 16.2.3.1. Overview
    • 16.2.3.2. Product Portfolio
    • 16.2.3.3. Sales Footprint
    • 16.2.3.4. Channel Footprint
    • 16.2.3.6. Strategy
      • 16.2.3.6.1. Marketing Strategy
      • 16.2.3.6.2. Product Strategy
      • 16.2.3.6.3. Channel Strategy
  • 16.2.4. Rite Aid Corp.
    • 16.2.4.1. Overview
    • 16.2.4.2. Product Portfolio
    • 16.2.4.3. Sales Footprint
    • 16.2.4.4. Channel Footprint
    • 16.2.4.6. Strategy
      • 16.2.4.6.1. Marketing Strategy
      • 16.2.4.6.2. Product Strategy
      • 16.2.4.6.3. Channel Strategy
  • 16.2.5. ProCare Rx.
    • 16.2.5.1. Overview
    • 16.2.5.2. Product Portfolio
    • 16.2.5.3. Sales Footprint
    • 16.2.5.4. Channel Footprint
    • 16.2.5.6. Strategy
      • 16.2.5.6.1. Marketing Strategy
      • 16.2.5.6.2. Product Strategy
      • 16.2.5.6.3. Channel Strategy
  • 16.2.6. UnitedHealth Group
    • 16.2.6.1. Overview
    • 16.2.6.2. Product Portfolio
    • 16.2.6.3. Sales Footprint
    • 16.2.6.4. Channel Footprint
    • 16.2.6.6. Strategy
      • 16.2.6.6.1. Marketing Strategy
      • 16.2.6.6.2. Product Strategy
      • 16.2.6.6.3. Channel Strategy
  • 16.2.7. Benecard Services, LLC
    • 16.2.7.1. Overview
    • 16.2.7.2. Product Portfolio
    • 16.2.7.3. Sales Footprint
    • 16.2.7.4. Channel Footprint
    • 16.2.7.6. Strategy
      • 16.2.7.6.1. Marketing Strategy
      • 16.2.7.6.2. Product Strategy
      • 16.2.7.6.3. Channel Strategy
  • 16.2.8. BioScrip, Inc.
    • 16.2.8.1. Overview
    • 16.2.8.2. Product Portfolio
    • 16.2.8.3. Sales Footprint
    • 16.2.8.4. Channel Footprint
    • 16.2.8.6. Strategy
      • 16.2.8.6.1. Marketing Strategy
      • 16.2.8.6.2. Product Strategy
      • 16.2.8.6.3. Channel Strategy
  • 16.2.9. CaptureRx
    • 16.2.9.1. Overview
    • 16.2.9.2. Product Portfolio
    • 16.2.9.3. Sales Footprint
    • 16.2.9.4. Channel Footprint
    • 16.2.9.6. Strategy
      • 16.2.9.6.1. Marketing Strategy
      • 16.2.9.6.2. Product Strategy
      • 16.2.9.6.3. Channel Strategy
  • 16.2.10. Change Healthcare
    • 16.2.10.1. Overview
    • 16.2.10.2. Product Portfolio
    • 16.2.10.3. Sales Footprint
    • 16.2.10.4. Channel Footprint
    • 16.2.10.6. Strategy
      • 16.2.10.6.1. Marketing Strategy
      • 16.2.10.6.2. Product Strategy
      • 16.2.10.6.3. Channel Strategy

17. Research Methodology